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EVALUATION OF THE PERSISTENCE OF DERIVATIZED
HYALURONIC ACID FOLLOWING INJECTION INTO THE
GUINEA PIG FEMOROPATELLAR FAT PAD TISSUES
S.M. Dethlefsen1, L-P. Yu1, N.M. Moran2, D.S. Garlick3,
E.M. Skrabut1
1Genzyme, Cambridge, MA; 2Genzyme, Framingham, MA;
3Charles River Laboratories, Worcester, MA
Purpose: Hyaluronan (HA) based viscosupplements are used to
reduce pain in patients with mild to moderate osteoarthritis. For
the patient to receive the full beneﬁt, these viscosupplements
must be injected directly into the joint space. Extra-articular
needle placement and injection of viscosupplements into the
subsynovial tissues may be linked to a higher incidence of
adverse reactions. In this study a guinea pig model was used
to investigate the cellular response to two viscosupplements,
non-animal stabilized hyaluronic acid (NASHA) and hylastan,
following injection into the fat pad to simulate misinjection of the
viscosupplement. These two crosslinked HA-based gels have
distinctly different rheological and physical properties. NASHA is
an epoxy crosslinked gel while hylastan is a non-animal HA gel
lightly crosslinked with divinyl sulfone.
Methods: Eighteen guinea pigs were randomized into two treat-
ment groups of 6 animals each and 1 HA control group (1% w/v
solution of unmodiﬁed HA) of 6 animals. Test or control material
was injected into the fat pad of the assigned animal. Fat pads in
the contra lateral joints were injected with lactated Ringer’s solu-
tion. Animals were sacriﬁced at 7 or 30 days following injection
and the fat pads ﬁxed in 4% paraformaldehyde for sectioning and
staining with hematoxylin and eosin (H&E). Some slides were
treated with hyaluronidase prior to staining with H&E to conﬁrm
the presence of HA-based material. The slides were examined
by a board certiﬁed veterinary pathologist for the presence of
residual HA-based material and cellular activity associated with
this material. Rheological properties were characterized by a
controlled stress rheometer and dynamic mechanical analysis.
Results: On day 7, residual HA-based material was observed
in tissues taken from both hylastan and NASHA-treated animals.
Test material was noted as a basophilic substance that formed
discrete clusters within the adipose tissue. The cellular response
to these two materials was characterized by the presence of
a thin layer of macrophages at the host-test material interface.
Macrophages appeared to easily inﬁltrate and degrade the mate-
rial in the hylastan-treated animals but not in the NASHA-treated
animals. No residual control material was present in tissues from
animals injected with the HA or lactated Ringer’s solution con-
trols. At day 30, residual hylastan was not observed in any of
the fat pad tissues. In contrast, residual NASHA was observed
as discrete aggregates of basophilic material associated with a
single layer of macrophages at the host material interface sur-
rounded by layers of ﬁbrous connective tissue that completely
encapsulated the material. Rheological measurements demon-
strate that hylastan is a softer, more cohesive gel than the
NASHA material.
Conclusions: We have evaluated the tissue distribution and
cellular activity of two HA-based test articles following injection
into the fat pads of guinea pigs. Microscopic analysis of the
cellular activity associated with the dissolution of hylastan was
quite different from that observed in tissue sections taken from
the NASHA-treated animals. Hylastan injected tissue demon-
strated a typical biomaterial response with macrophages that
are facilitating the resorption of implanted material at early time-
points. This inﬂammatory response resolves at later times once
the hylastan is completely resorbed. The NASHA injected tis-
sue demonstrated a similar early time response, but at the later
times showed a cellular and ﬁbrous encapsulation of the injected
material.
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ALPHA-2-MACROGLOBULIN INHIBITS THE
DEGRADATIVE ACTIVITIES OF ADAMTS-7 AND
ADAMTS-12
Y. Luan, D.R. Howell, K. Li, C. Liu
New York University, New York, NY
Purpose: We previously reported that ADAMTS-7 and ADAMTS-
12, two members of ADAMTS (a disintegrin and metalloprotease
with thrombospondin motifs) family, sharing the similar domain
organization in the family, degraded COMP in vitro and were
signiﬁcantly induced in the cartilage and synovium of arthritic
patients (Liu, et al, FASEB J. 2006; 20(7):988 and Liu, et al,
J. Biol. Chem. 2006; 281(23):15800). The purpose of this study
was to determine 1) whether cleavage activity of ADAMTS-
7 and -12 of COMP are associated with COMP degradation in
osteoarthritis; 2) whether a2M is a novel substrate for ADAMTS-7
and -12; and 3) whether a2M inhibits ADAMTS-7 or -12 cleavage
of COMP.
Methods: In vitro digestion assay of COMP by ADAMTS-7 and
ADAMTS-12; COMP degradation analyses in the cartilage of
OA patients; COMP degradation assay from the organ culturing
system in the presence of TNF-α with or without blocking anti-
bodies; COMP degradation assay from human chondrocytes in
which expressions of ADAMTS-7 or/and -12 were knock-down
by speciﬁc siRNA; Digestion of alpha-2-macroglobulin (a2M) by
ADAMTS-7 and -12 in vitro as well as the inhibition assays of
α2M on ADAMTS-7 or -12 digestion of COMP.
Results: The size of the COMP fragments produced by ei-
ther ADAMTS-7 or ADAMTS-12 is similar to that of COMP-
degradative fragments seen in OA patients; antibody blocking
assay indicated that speciﬁc antibodies against ADAMTS-7 or
ADAMTS-12 dramatically inhibits TNF-α-induced COMP degra-
dation in the cultured cartilage explants; and suppression of
ADAMTS-7 or ADAMTS-12 expression using siRNA silencing ap-
proach in the human chondrocytes also markedly prevents TNF-
α-induced COMP degradation. Both ADAMTS-7 and ADAMTS-
12 metalloproteinases were able to cleave α2M in a dose-
dependent manner, which gave rise to the cleavage products
with the molecular weights of 180 and 105 kDa respectively. Fur-
ther, α2M inhibits both ADAMTS-7- and ADAMTS-12-mediated
COMP degradation in a does-dependent manner.
Conclusions: Our observation demonstrated the importance
of COMP degradation by ADAMTS-7 and ADAMTS-12 in vivo;
furthermore, we revealed that α2-Macroglobulin (α2M) is a novel
substrate for ADAMTS-7 and ADAMTS-12. More signiﬁcantly,
α2M represents the ﬁrst endogenous inhibitor of ADAMTS-7 and
ADAMTS-12.
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EVIDENCE THAT THE NEUTRAL ACTIVE
HYALURONIDASE PH-20 CONTRIBUTES TO THE
BREAKDOWN OF CARTILAGE MATRIX IN HUMAN KNEE
OSTEOARTHRITIS
D.H. Manicourt, J-P. Devogelaer, J-E. Dubuc, C. Galant
Université Catholique de Louvain, Brussels, Belgium
Purpose: The discovery that chondrocytes, synoviocytes and
dermal ﬁbroblasts all produce a neutral active hyaluronidase sim-
ilar to the sperm or testicular hyaluronidase PH-20 might provide
new and important insights into mechanisms implicated during
embryogenesis and during the development of skin and joint
disorders. Therefore, we herein assessed the levels of PH-20 ex-
pression in human normal and osteoarthritic articular cartilage.
